All Articles

A Chinese city is investing billions to become a global satellite hub, unveiling ambitious plans for carbon monitoring and international partnerships. Is this a tech boom or a new front in space geopolitics?

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

As Canada's new AI Minister prepares to address Toronto's elite, he carries a multi-billion-dollar plan. But can policy bridge the gap from research to reality?

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.

With a new CEO known for scaling data-driven platforms, OWL AI is moving beyond officiating to become the foundational intelligence layer for live sports.

As new regulations unleash a flood of bond market data, MarketAxess's TraX Tape uses AI and a decade of refinement to turn chaos into actionable intelligence.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Hisense's VAR role at the World Cup is more than a tech deal. It's a high-stakes play to enhance game integrity, dominate a market, and redefine fan experience.

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

Century 21 Canada reports a stunning 39% growth surge in Quebec. Is this a fluke, or a new blueprint for challenging market leaders with tech and local focus?

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.

As air disc brakes become the new standard, DRiV's Abex brand moves beyond parts to offer an integrated system, simplifying maintenance and boosting safety.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.